214 related articles for article (PubMed ID: 29956291)
61. DNA/RNA hybrid substrates modulate the catalytic activity of purified AID.
Abdouni HS; King JJ; Ghorbani A; Fifield H; Berghuis L; Larijani M
Mol Immunol; 2018 Jan; 93():94-106. PubMed ID: 29161581
[TBL] [Abstract][Full Text] [Related]
62. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
[TBL] [Abstract][Full Text] [Related]
63. APOBEC-mediated editing of viral RNA.
Bishop KN; Holmes RK; Sheehy AM; Malim MH
Science; 2004 Jul; 305(5684):645. PubMed ID: 15286366
[TBL] [Abstract][Full Text] [Related]
64. Activation-induced cytidine deaminase acts on double-strand breaks in vitro.
Shen HM
Mol Immunol; 2007 Feb; 44(5):974-83. PubMed ID: 16697045
[TBL] [Abstract][Full Text] [Related]
65. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
[TBL] [Abstract][Full Text] [Related]
66. Mutations in human AID differentially affect its ability to deaminate cytidine and 5-methylcytidine in ssDNA substrates in vitro.
Budzko L; Jackowiak P; Kamel K; Sarzynska J; Bujnicki JM; Figlerowicz M
Sci Rep; 2017 Jun; 7(1):3873. PubMed ID: 28634398
[TBL] [Abstract][Full Text] [Related]
67. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.
Yu Q; König R; Pillai S; Chiles K; Kearney M; Palmer S; Richman D; Coffin JM; Landau NR
Nat Struct Mol Biol; 2004 May; 11(5):435-42. PubMed ID: 15098018
[TBL] [Abstract][Full Text] [Related]
68. Hydrolytic nucleoside and nucleotide deamination, and genetic instability: a possible link between RNA-editing enzymes and cancer?
Anant S; Davidson NO
Trends Mol Med; 2003 Apr; 9(4):147-52. PubMed ID: 12727140
[TBL] [Abstract][Full Text] [Related]
69. Diversification of AID/APOBEC-like deaminases in metazoa: multiplicity of clades and widespread roles in immunity.
Krishnan A; Iyer LM; Holland SJ; Boehm T; Aravind L
Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3201-E3210. PubMed ID: 29555751
[TBL] [Abstract][Full Text] [Related]
70. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.
DeWeerd RA; Németh E; Póti Á; Petryk N; Chen CL; Hyrien O; Szüts D; Green AM
Cell Rep; 2022 Mar; 38(12):110555. PubMed ID: 35320711
[TBL] [Abstract][Full Text] [Related]
71. New Insights Into the Lineage-Specific Expansion and Functional Diversification of Lamprey AID/APOBEC Family.
Chen Y; Luo L; Deng L; Tian X; Chen S; Xu A; Yuan S
Front Immunol; 2022; 13():822616. PubMed ID: 35359986
[TBL] [Abstract][Full Text] [Related]
72. Secreted novel AID/APOBEC-like deaminase 1 (SNAD1) - a new important player in fish immunology.
Majewska AM; Dietrich MA; Budzko L; Adamek M; Figlerowicz M; Ciereszko A
Front Immunol; 2024; 15():1340273. PubMed ID: 38601149
[TBL] [Abstract][Full Text] [Related]
73. Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A.
Carpenter MA; Li M; Rathore A; Lackey L; Law EK; Land AM; Leonard B; Shandilya SM; Bohn MF; Schiffer CA; Brown WL; Harris RS
J Biol Chem; 2012 Oct; 287(41):34801-8. PubMed ID: 22896697
[TBL] [Abstract][Full Text] [Related]
74. Single-Nucleotide Resolution Analysis of 5-Hydroxymethylcytosine in DNA by Enzyme-Mediated Deamination in Combination with Sequencing.
Li QY; Xie NB; Xiong J; Yuan BF; Feng YQ
Anal Chem; 2018 Dec; 90(24):14622-14628. PubMed ID: 30457326
[TBL] [Abstract][Full Text] [Related]
75. Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis.
Shilova ON; Tsyba DL; Shilov ES
Mol Biol; 2022; 56(1):46-58. PubMed ID: 35194245
[TBL] [Abstract][Full Text] [Related]
76. Mutagenesis by AID, a molecule critical to immunoglobulin hypermutation, is not caused by an alteration of the precursor nucleotide pool.
Diaz M; Ray M; Wheeler LJ; Verkoczy LK; Mathews CK
Mol Immunol; 2003 Sep; 40(5):261-8. PubMed ID: 12943798
[TBL] [Abstract][Full Text] [Related]
77. APOBEC3 proteins and genomic stability: the high cost of a good defense.
Narvaiza I; Landry S; Weitzman MD
Cell Cycle; 2012 Jan; 11(1):33-8. PubMed ID: 22157092
[TBL] [Abstract][Full Text] [Related]
78. APOBECs orchestrate genomic and epigenomic editing across health and disease.
Cervantes-Gracia K; Gramalla-Schmitz A; Weischedel J; Chahwan R
Trends Genet; 2021 Nov; 37(11):1028-1043. PubMed ID: 34353635
[TBL] [Abstract][Full Text] [Related]
79. APOBEC1 cytosine deaminase activity on single-stranded DNA is suppressed by replication protein A.
Wong L; Vizeacoumar FS; Vizeacoumar FJ; Chelico L
Nucleic Acids Res; 2021 Jan; 49(1):322-339. PubMed ID: 33330905
[TBL] [Abstract][Full Text] [Related]
80. The current structural and functional understanding of APOBEC deaminases.
Bransteitter R; Prochnow C; Chen XS
Cell Mol Life Sci; 2009 Oct; 66(19):3137-47. PubMed ID: 19547914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
